Global Genomics Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

Description

List of Tables

The Global Genomics Services market is forecasted to grow at a noteworthy CAGR of 11.66% between 2025 and 2033. By 2033, market size is expected to surge to USD 24.31 Billion, a substantial rise from the USD 9.01 Billion recorded in 2024.

The genomics services market is experiencing exponential growth fueled by breakthroughs in sequencing technologies, bioinformatics, and personalized medicine. Genomics services encompass a broad spectrum of offerings, including whole-genome sequencing, gene expression analysis, and variant interpretation, supporting research, clinical diagnostics, and drug development. The dramatic reduction in sequencing costs and turnaround times is democratizing access to genomic data, enabling large-scale population studies and precision healthcare applications. Cloud-based platforms and AI-driven analytics are enhancing data processing capabilities, facilitating actionable insights from complex genomic datasets.

The integration of genomics with other omics disciplines and electronic health records is advancing multi-dimensional patient profiling, improving disease risk prediction, diagnosis, and treatment customization. Regulatory frameworks and data privacy considerations are shaping service delivery models, emphasizing secure data management and ethical use. The expansion of direct-to-consumer genomics and pharmacogenomics services is increasing public engagement and awareness. Additionally, collaborations between academic institutions, biotech firms, and healthcare providers are accelerating translational research and clinical adoption.

As genomics becomes central to the future of medicine and biotechnology, the market is poised for sustained growth, driving innovation in diagnostics, therapeutics, and population health management.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the Genomics Services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

Next Generation Sequencing
Genotyping
Microarray
Sanger Sequencing
Other Services

By Application

Research
Diagnostics

By End Use

Research Institutes
Diagnostic Centers
Pharmaceutical and Biotechnological Companies
Contract Research Organizations (CROs)
Other End Use
List of Companies Profiled in the report
23andMe, Agilent Technologies, BGI Genomics, Bio Rad Laboratories, Color Genomics, Danaher, Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, GENEWIZ (Azenta), Illumina, LGC, Macrogen, IQVIA, QIAGEN

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112117547

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. GENOMICS SERVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Service Type
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY SERVICE TYPE

5.1. Overview By Service Type
5.2. Historical and Forecast Data Analysis By Service Type
5.3. Next Generation Sequencing Historic and Forecast Sales By Regions
5.4. Genotyping Historic and Forecast Sales By Regions
5.5. Microarray Historic and Forecast Sales By Regions
5.6. Sanger Sequencing Historic and Forecast Sales By Regions
5.7. Other Services Historic and Forecast Sales By Regions

6. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data Analysis By Application
6.3. Research Historic and Forecast Sales By Regions
6.4. Diagnostics Historic and Forecast Sales By Regions

7. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data Analysis By End Use
7.3. Research Institutes Historic and Forecast Sales By Regions
7.4. Diagnostic Centers Historic and Forecast Sales By Regions
7.5. Pharmaceutical and Biotechnological Companies Historic and Forecast Sales By Regions
7.6. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
7.7. Other End Use Historic and Forecast Sales By Regions

8. GLOBAL GENOMICS SERVICES MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE GENOMICS SERVICES COMPANIES

9.1. Genomics Services Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF GENOMICS SERVICES INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. 23andMe
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Agilent Technologies
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. BGI Genomics
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Bio Rad Laboratories
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Color Genomics
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Danaher
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Eurofins Scientific
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. F. Hoffmann-La Roche
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. GE Healthcare
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. GENEWIZ (Azenta)
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Illumina
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. LGC
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Macrogen
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. IQVIA
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. QIAGEN
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies